A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.
The involvement of platelet activating factor (PAF) in anaphylaxis was examined by recording the pulmonary responses of anesthetized passively sensitized guinea-pigs to the aerosolization of ovalbumin. Animals were tested with and without BN 52021 (a ginkgolide B, PAF receptor antagonist) pretreatment. Aerosolization of ovalbumin produced a bronchoconstriction (BC) which could be made refractory to additional challenges with the antigen. In animals desensitized to ovalbumin, aerosolization of PAF produced an unattenuated BC. Guinea pigs desensitized by repeated aerosolizations of PAF subsequently showed reduced responses to aerosolized antigen suggesting that PAF may be involved in the BC. Animals pretreated with BN 52021, were protected against the effects of systemically administered PAF and also showed reduced responses to aerosolized antigen. Aerosolization of the leukotriene antagonist, FPL 55712, was ineffective against anaphylactic BC under conditions where catecholamine and histamine release were blocked.
D000336:Aerosols; D000707:Anaphylaxis / Q000503:physiopathology*; D000818:Animals; D001792:Blood Platelets / Q000502:physiology; D004224:Diterpenes; D005260:Female; D046934:Ginkgolides; D006168:Guinea Pigs; D007073:Immunoglobulin E; D007783:Lactones; D008297:Male; D009504:Neutrophils / Q000502:physiology; D010047:Ovalbumin; D010936:Plant Extracts / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000502:physiology*; D011433:Propranolol / Q000494:pharmacology
D000336:Aerosols; D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010936:Plant Extracts; D010972:Platelet Activating Factor; D007073:Immunoglobulin E; D010047:Ovalbumin; D011433:Propranolol; C045856:ginkgolide B